Fate Therapeutics Inc (FATE)
3.91
-0.23
(-5.56%)
USD |
NASDAQ |
May 17, 16:00
3.91
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Accounts Receivable (Quarterly): 0.858M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.858M |
December 31, 2023 | 1.826M |
September 30, 2023 | 1.538M |
June 30, 2023 | 2.833M |
March 31, 2023 | 13.50M |
December 31, 2022 | 38.48M |
September 30, 2022 | 10.22M |
June 30, 2022 | 13.13M |
March 31, 2022 | 13.85M |
December 31, 2021 | 8.676M |
September 30, 2021 | 7.311M |
June 30, 2021 | 10.30M |
March 31, 2021 | 6.945M |
December 31, 2020 | 5.515M |
September 30, 2020 | 3.243M |
June 30, 2020 | 1.717M |
March 31, 2020 | |
December 31, 2019 | 0.00 |
Date | Value |
---|---|
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.50M |
December 31, 2018 | 0.50M |
September 30, 2018 | 0.50M |
June 30, 2018 | |
March 31, 2018 | 0.50M |
December 31, 2017 | 0.00 |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | 0.846M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
38.48M
Maximum
Dec 2022
7.366M
Average
5.515M
Median
Dec 2020
Accounts Receivable (Quarterly) Benchmarks
Amicus Therapeutics Inc | 76.43M |
Sarepta Therapeutics Inc | 378.81M |
ADMA Biologics Inc | 49.62M |
Ocular Therapeutix Inc | 26.55M |
Viking Therapeutics Inc | -- |